Natixis Advisors LLC Has $1.33 Million Stock Position in Core Scientific, Inc. (NASDAQ:CORZ)

Natixis Advisors LLC increased its position in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 345.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 94,573 shares of the company's stock after buying an additional 73,319 shares during the period. Natixis Advisors LLC's holdings in Core Scientific were worth $1,329,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Picton Mahoney Asset Management increased its holdings in Core Scientific by 105.5% during the 4th quarter. Picton Mahoney Asset Management now owns 277,437 shares of the company's stock worth $3,899,000 after purchasing an additional 142,437 shares during the last quarter. Wellington Shields & Co. LLC acquired a new stake in shares of Core Scientific during the fourth quarter worth approximately $26,000. Wellington Shields Capital Management LLC acquired a new stake in shares of Core Scientific during the fourth quarter worth approximately $333,000. Mercuria Capital Strategies LLC bought a new stake in shares of Core Scientific in the fourth quarter worth $2,459,000. Finally, Vestcor Inc acquired a new stake in Core Scientific in the fourth quarter valued at $66,000.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, CEO Adam Taylor Sullivan sold 369,712 shares of the stock in a transaction on Friday, January 24th. The stock was sold at an average price of $16.24, for a total transaction of $6,004,122.88. Following the completion of the transaction, the chief executive officer now directly owns 3,758,793 shares of the company's stock, valued at approximately $61,042,798.32. This trade represents a 8.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jordan Levy acquired 62,500 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were bought at an average price of $8.01 per share, with a total value of $500,625.00. Following the transaction, the director now directly owns 306,887 shares in the company, valued at approximately $2,458,164.87. The trade was a 25.57 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have sold 748,282 shares of company stock valued at $10,978,104. Company insiders own 32.00% of the company's stock.

Remove Ads

Core Scientific Price Performance

Shares of CORZ stock traded down $0.40 during trading hours on Friday, reaching $7.48. The stock had a trading volume of 44,053,519 shares, compared to its average volume of 11,579,443. The firm has a 50-day simple moving average of $10.89 and a 200-day simple moving average of $13.10. The firm has a market capitalization of $2.20 billion, a PE ratio of -1.38 and a beta of 6.83. Core Scientific, Inc. has a twelve month low of $2.61 and a twelve month high of $18.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.09. The business had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million. On average, equities analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CORZ has been the subject of several recent analyst reports. Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a research report on Monday, January 27th. They issued an "outperform" rating and a $22.00 target price for the company. Needham & Company LLC decreased their price target on Core Scientific from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Thursday, February 27th. Cantor Fitzgerald cut their price objective on Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Canaccord Genuity Group reaffirmed a "buy" rating and set a $17.00 target price on shares of Core Scientific in a report on Wednesday, March 12th. Finally, Craig Hallum assumed coverage on Core Scientific in a report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price target for the company. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Core Scientific presently has a consensus rating of "Buy" and a consensus price target of $19.07.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.